- RIUMA Principal
- Listar por autor
Listar por autor "Madrigal-Burgaleta, R."
Mostrando ítems 1-2 de 2
-
Basophil activation test is a complementary tool in the diagnosis of immediate reactions to platinum salts and taxanes
Bogas, Gador; Ariza, Adriana; Vázquez-Revuelta, Paula; Labella, Marina; Madrigal-Burgaleta, R.; Fernández-Santamaría, Rubén; Calvo-Serrano, Silvia; Villar-Chamorro, Esther; Martín-Clavo, Susana; Lebrón-Martín, Clara; Mayorga, Cristobalina; Doña, Inmaculada; Torres, María J.[et al.] (Wiley, 2024)Background Delabelling pathways offer confirmatory diagnosis and can prevent unnecessary second-line therapies or drug desensitization procedures after chemotherapeutic hypersensitivity reactions (CHT-HSRs). However, these ... -
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper
Mayorga Mayorga, Cristobalina; Çelik, G.E.; Pascal, M.; Hoffmann, H.J.; Eberlein, B.; Torres-Jaén, María Josefa; Brockow, K.; Garvey, L.H.; Barbaud, A.; Madrigal-Burgaleta, R.; Caubet, J.C.; Ebo, D.G.[et al.] (Wiley, 2023-11-13)Diagnosing immediate drug hypersensitivity reactions (IDHRs) can pose a significant challenge and there is an urgent need for safe and reliable tests. Evidence has emerged that the basophil activation test (BAT), an in ...